Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1073
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Current evidence and the evolving role of sunitinib in the management of renal cell carcinoma

Noronha V, Joshi A, Bakshi G, Tongaonkar H, Prabhash K

Year : 2016| Volume: 53| Issue : 1 | Page no: 102-108

   This article has been cited by
1 Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Caroline Randrup Hansen,Daniela Grimm,Johann Bauer,Markus Wehland,Nils Magnusson
International Journal of Molecular Sciences. 2017; 18(2): 461
[Pubmed]  [Google Scholar] [DOI]
2 Prognostic significance of platelet–lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer
Tae Ju Park,Yang Hyun Cho,Ho Seok Chung,Eu Chang Hwang,Sung-Hoon Jung,Jun Eul Hwang,Woo Kyun Bae,Jin Woong Kim,Suk Hee Heo,Young Hoe Hur,Seung Il Jung,Dong Deuk Kwon
SpringerPlus. 2016; 5(1)
[Pubmed]  [Google Scholar] [DOI]


  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow